AR affects between 10% and 40% of the population. Around 80% of patients develop AR before the age of 20. The World Allergy Organization defines AR as a symptomatic nasal disorder caused by immunoglobulin E (IgE)- mediated inflammation of the membranes lining the nose after exposure to an allergen. AR can significantly impact the quality of life, leading...